Protective effect of mitochondria‑targeted peptide MTP‑131 against oxidative stress‑induced apoptosis in RGC‑5 cells

Chen,Min; Liu,Bingqian; Ma,Jian; Ge,Jian; Wang,Kaijun

doi:10.3892/mmr.2017.6271

Protective effect of mitochondria‑targeted peptide MTP‑131 against oxidative stress‑induced apoptosis in RGC‑5 cells

Authors:
- Min Chen
- Bingqian Liu
- Jian Ma
- Jian Ge
- Kaijun Wang
View Affiliations

Affiliations: Eye Center, The 2nd Affiliated Hospital, Medical College of Zhejiang University, Zhejiang Provincial Key Lab of Ophthalmology, Hangzhou, Zhejiang 310009, P.R. China, State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat‑sen University, Guangzhou, Guangdong 510060, P.R. China
Published online on: March 1, 2017 https://doi.org/10.3892/mmr.2017.6271
Pages: 2179-2185
Copyright: © Chen et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The retina of the human eye is extremely vulnerable to oxidative damage. Previous studies have demonstrated that oxidative stress is the predominant mechanism associated with the pathogenesis of age‑related macular degeneration, diabetic retinopathy, glaucoma and retinitis pigmentosa. MTP‑131, a novel mitochondria‑targeted peptide, has been demonstrated to specifically concentrate in the inner mitochondria membrane and to exhibit remarkable antioxidant effects both in vitro and in animal models. In the present study, the protective effect of MTP‑131 was evaluated in response to hydrogen peroxide (H2O2)‑induced oxidative damage in a retinal ganglion cell line, RGC‑5. Cell viability was measured by lactate dehydrogenase (LDH) assay. Changes of mitochondrial membrane potential and generation of intracellular reactive oxygen species (ROS) were measured by flow cytometry and confocal microscopy, respectively. Annexin V‑fluorescein isothiocyanate/propidium iodide staining was used for assessment of apoptosis. Release of cytochrome c was analyzed by confocal microscopy. Pretreatment of cells with MTP‑131 inhibited H2O2‑induced cytotoxicity and reduced LDH release in a dose‑dependent manner, compared with cells treated with H2O2 alone. Mitochondrial depolarization and ROS generation were also prevented by MTP‑131 pretreatment. In addition, MTP‑131 pretreatment inhibited cytochrome c release from mitochondria to cytoplasm, and significantly reduced apoptosis in RGC‑5 cells, compared with cells treated with H2O2 alone. In conclusion, mitochondria‑targeted peptide MTP‑131 exhibited a protective effect against oxidative stress‑induced apoptosis in RGC‑5 cells, which may provide a novel approach for the treatment of age‑associated retinal diseases.

View Figures

View References

1	Bhat AH, Dar KB, Anees S, Zargar MA, Masood A, Sofi MA and Ganie SA: Oxidative stress, mitochondrial dysfunction and neurodegenerative diseases; a mechanistic insight. Biomed Pharmacother. 74:101–110. 2015. View Article : Google Scholar : PubMed/NCBI
2	Thanan R, Oikawa S, Hiraku Y, Ohnishi S, Ma N, Pinlaor S, Yongvanit P, Kawanishi S and Murata M: Oxidative stress and its significant roles in neurodegenerative diseases and cancer. Int J Mol Sci. 16:193–217. 2014. View Article : Google Scholar : PubMed/NCBI
3	Bonilha VL, Rayborn ME, Yang X, Xie C and Cai H: Oxidative stress regulation by DJ-1 in the retinal pigment epithelium. Adv Exp Med Biol. 801:649–654. 2014. View Article : Google Scholar : PubMed/NCBI
4	Wu Y, Tang L and Chen B: Oxidative stress: Implications for the development of diabetic retinopathy and antioxidant therapeutic perspectives. Oxid Med Cell Longev. 2014:7523872014. View Article : Google Scholar : PubMed/NCBI
5	Pinazo-Durán MD, Gallego-Pinazo R, García-Medina JJ, Zanón-Moreno V, Nucci C, Dolz-Marco R, Martínez-Castillo S, Galbis-Estrada C, Marco-Ramírez C, López-Gálvez MI, et al: Oxidative stress and its downstream signaling in aging eyes. Clin Interv Aging. 9:637–652. 2014. View Article : Google Scholar : PubMed/NCBI
6	Campochiaro PA, Strauss RW, Lu L, Hafiz G, Wolfson Y, Shah SM, Sophie R, Mir TA and Scholl HP: Is there excess oxidative stress and damage in eyes of patients with retinitis pigmentosa? Antioxid Redox Signal. 23:643–648. 2015. View Article : Google Scholar : PubMed/NCBI
7	Zhao K, Zhao GM, Wu D, Soong Y, Birk AV, Schiller PW and Szeto HH: Cell-permeable peptide antioxidants targeted to inner mitochondrial membrane inhibit mitochondrial swelling, oxidative cell death, and reperfusion injury. J Biol Chem. 279:34682–34690. 2004. View Article : Google Scholar : PubMed/NCBI
8	Zhao K, Luo G, Zhao GM, Schiller PW and Szeto HH: Transcellular transport of a highly polar 3+ net charge opioid tetrapeptide. J Pharmacol Exp Ther. 304:425–432. 2003. View Article : Google Scholar : PubMed/NCBI
9	Zhao K, Luo G, Giannelli S and Szeto HH: Mitochondria-targeted peptide prevents mitochondrial depolarization and apoptosis induced by tert-butyl hydroperoxide in neuronal cell lines. Biochem Pharmacol. 70:1796–1806. 2005. View Article : Google Scholar : PubMed/NCBI
10	Szeto HH: Mitochondria-targeted peptide antioxidants: Novel neuroprotective agents. AAPS J. 8:E521–E531. 2006. View Article : Google Scholar : PubMed/NCBI
11	Iizuka Y, Hong S, Kim CY, Kim SK and Seong GJ: Agmatine pretreatment protects retinal ganglion cells (RGC-5 cell line) from oxidative stress in vitro. Biocell. 32:245–250. 2008.PubMed/NCBI
12	Shimazawa M, Nakajima Y, Mashima Y and Hara H: Docosahexaenoic acid (DHA) has neuroprotective effects against oxidative stress in retinal ganglion cells. Brain Res. 1251:269–275. 2009. View Article : Google Scholar : PubMed/NCBI
13	Chen M, Liu B, Gao Q, Zhuo Y and Ge J: Mitochondria-targeted peptide MTP-131 alleviates mitochondrial dysfunction and oxidative damage in human trabecular meshwork cells. Invest Ophthalmol Vis Sci. 52:7027–7037. 2011. View Article : Google Scholar : PubMed/NCBI
14	Koriyama Y, Ohno M, Kimura T and Kato S: Neuroprotective effects of 5-S-GAD against oxidative stress-induced apoptosis in RGC-5 cells. Brain Res. 1296:187–195. 2009. View Article : Google Scholar : PubMed/NCBI
15	Zhou X, Su CF, Zhang Z, Wang CY, Luo JQ, Zhou XW, Cai L, Yan L, Zhang W and Luo HM: Neuroprotective effects of methyl 3,4-dihydroxybenzoate against H2O2-induced apoptosis in RGC-5 cells. J Pharmacol Sci. 125:51–58. 2014. View Article : Google Scholar : PubMed/NCBI
16	Jia WC, Liu G, Zhang CD and Zhang SP: Formononetin attenuates hydrogen peroxide (H2O2)-induced apoptosis and NF-κB activation in RGC-5 cells. Eur Rev Med Pharmacol Sci. 18:2191–2197. 2014.PubMed/NCBI
17	Wang R, Peng L, Zhao J, Zhang L, Guo C, Zheng W and Chen H: Gardenamide A protects RGC-5 cells from H2O2-induced oxidative stress insults by activating PI3K/Akt/eNOS signaling pathway. Int J Mol Sci. 16:22350–22367. 2015. View Article : Google Scholar : PubMed/NCBI
18	Zhang P, Huang C, Wang W and Wang M: Early changes in staurosporine-induced differentiated RGC-5 cells indicate cellular injury response to nonlethal blue light exposure. Photochem Photobiol Sci. 14:1093–1099. 2015. View Article : Google Scholar : PubMed/NCBI
19	Ding W, Shang L, Huang JF, Li N, Chen D, Xue LX and Xiong K: Receptor interacting protein 3-induced RGC-5 cell necroptosis following oxygen glucose deprivation. BMC Neurosci. 16:492015. View Article : Google Scholar : PubMed/NCBI
20	Sippl C and Tamm ER: What is the nature of the RGC-5 cell line? Adv Exp Med Biol. 801:145–154. 2014. View Article : Google Scholar : PubMed/NCBI
21	Al-Ubaidi MR: RGC-5: Are they really 661W? The saga continues. Exp Eye Res. 119:1152014. View Article : Google Scholar : PubMed/NCBI
22	Mao H, Seo SJ, Biswal MR, Li H, Conners M, Nandyala A, Jones K, Le YZ and Lewin AS: Mitochondrial oxidative stress in the retinal pigment epithelium leads to localized retinal degeneration. Invest Ophthalmol Vis Sci. 55:4613–4627. 2014. View Article : Google Scholar : PubMed/NCBI
23	Birk AV, Chao WM, Bracken C, Warren JD and Szeto HH: Targeting mitochondrial cardiolipin and the cytochrome c/cardiolipin complex to promote electron transport and optimize mitochondrial ATP synthesis. Br J Pharmacol. 171:2017–2028. 2014. View Article : Google Scholar : PubMed/NCBI
24	Szeto HH: First-in-class cardiolipin-protective compound as a therapeutic agent to restore mitochondrial bioenergetics. Br J Pharmacol. 171:2029–2050. 2014. View Article : Google Scholar : PubMed/NCBI
25	Wu J, Zhang M, Hao S, Jia M, Ji M, Qiu L, Sun X, Yang J and Li K: Mitochondria-targeted peptide reverses mitochondrial dysfunction and cognitive deficits in sepsis-associated encephalopathy. Mol Neurobiol. 52:783–791. 2015. View Article : Google Scholar : PubMed/NCBI
26	Ajith TA and Jayakumar TG: Mitochondria-targeted agents: Future perspectives of mitochondrial pharmaceutics in cardiovascular diseases. World J Cardiol. 6:1091–1099. 2014. View Article : Google Scholar : PubMed/NCBI
27	Birk AV, Liu S, Soong Y, Mills W, Singh P, Warren JD, Seshan SV, Pardee JD and Szeto HH: The mitochondrial-targeted compound SS-31 re-energizes ischemic mitochondria by interacting with cardiolipin. J Am Soc Nephrol. 24:1250–1261. 2013. View Article : Google Scholar : PubMed/NCBI